<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000439423">
  <TermName>psoralen and ultraviolet A therapy</TermName>
  <TermPronunciation>(SOR-uh-len…UL-truh-VY-oh-let A THAYR-uh-pee)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A type of photodynamic therapy used to treat skin conditions such as psoriasis, vitiligo, and skin nodules of cutaneous T-cell lymphoma. The patient receives psoralen (a drug that becomes active when it is exposed to light) by mouth or applied to the skin, followed by ultraviolet A radiation. Psoralen and ultraviolet A therapy may increase the risk of getting skin cancer. Also called PUVA therapy.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000713794" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;psoralen and ultraviolet A therapy&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000713795" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;terapia con psoraleno y radiación ultravioleta A&quot;" language="es" id="_4"/>
  <SpanishTermName>terapia con psoraleno y radiación ultravioleta A</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Tipo de terapia fotodinámica que se usa para tratar afecciones de la piel, como la psoriasis, el vitiligo y los nódulos del linfoma cutáneo de células T. Se administra psoraleno (un medicamento que se activa al exponerse a la luz) por la boca o en la piel, seguido de radiación ultravioleta A. Es posible que la terapia con psoraleno y radiación ultravioleta A aumente el riesgo de cáncer de piel. También se llama terapia con PUVA.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2005-07-08</DateFirstPublished>
  <DateLastModified>2008-02-19</DateLastModified>
</GlossaryTerm>
